APA (7th ed.) Citation

J, Y., Q, T., YY, C., KY, L., SS, N., KF, C., . . . JJ, S. (2009). Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer (0008543X), 115(1), 49. https://doi.org/10.1002/cncr.23989

Chicago Style (17th ed.) Citation

J, Yu, et al. "Promoter Methylation of the Wnt/beta-catenin Signaling Antagonist Dkk-3 Is Associated with Poor Survival in Gastric Cancer." Cancer (0008543X) 115, no. 1 (2009): 49. https://doi.org/10.1002/cncr.23989.

MLA (9th ed.) Citation

J, Yu, et al. "Promoter Methylation of the Wnt/beta-catenin Signaling Antagonist Dkk-3 Is Associated with Poor Survival in Gastric Cancer." Cancer (0008543X), vol. 115, no. 1, 2009, p. 49, https://doi.org/10.1002/cncr.23989.